Inari Medical【NARI】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

51.53

買値

51.51

売値

51.60

出来高

237,816

50.77 日の範囲 51.985

36.73 52 週間の範囲 67.13

時価総額

3.017B

前日終値

51.55

始値

51.51

時刻

51.5616

最終取引時間

04:05:04

財務取引量

US$ 12,266,837

VWAP

51.5812

平均取引量 (3 か月)

850,805

発行済株式数

58,544,158

配当利回り

PER

-1,846.59

1 株当たり利益 (EPS)

-0.03

歳入

493.63M

純利益

-1.64M

Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreive... Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States. 詳細を表示

セクター

Surgical,med Instr,apparatus

業界

Surgical,med Instr,apparatus

ウェブサイト

www.inarimedical.com

本社

Wilmington, Delaware, USA

設立

Inari Medical Inc is listed in the Surgical,med Instr,apparatus sector of the ナスダック市場 with ticker NARI. The last closing price for Inari Medical was US$51.55. Over the last year, Inari Medical shares have traded in a share price range of US$ 36.73 to US$ 67.13.

Inari Medical currently has 58,544,158 shares in issue. The market capitalisation of Inari Medical is US$3.02 billion. Inari Medical has a price to earnings ratio (PE ratio) of -1846.59.

Form 4 - Statement of changes in beneficial ownership of securities

Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering...

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.43	0.841487279843	51.1	53.065	50.4	553263	51.7041492	CS
4	-0.27	-0.521235521236	51.8	53.67	47.96	734589	51.08852656	CS
12	7.13	16.0585585586	44.4	53.67	39.76	850805	46.19190209	CS
26	1.48	2.95704295704	50.05	59.9	39.76	841738	47.42985169	CS
52	-9.47	-15.5245901639	61	67.13	36.73	944751	48.10418557	CS
156	-27.18	-34.5318256892	78.71	100	36.73	792701	59.85377265	CS
260	10.23	24.7699757869	41.3	127.42	36.73	693161	65.51237703	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
CYCNCyclerion Therapeutics Inc	US$ 7.30 (353.42%)	114.91M
SMXSMX Security Matters Public Company	US$ 0.5322 (173.20%)	486.26M
CNEYCN Energy Group Inc	US$ 0.5802 (83.84%)	149.36M
SRMSRM Entertainment Inc	US$ 1.1301 (79.35%)	132.23M
HTOOFusion Fuel Green PLC	US$ 0.5351 (68.27%)	268.77M
RLMDRelmada Therapeutics Inc	US$ 0.639249 (-76.92%)	14.24M
MIGIMawson Infrastructure Group Inc	US$ 0.8672 (-54.60%)	11.19M
MONDMondee Holdings Inc	US$ 0.2005 (-32.06%)	2.65M
ORISOriental Rise Holdings Ltd	US$ 8.45 (-29.29%)	511.31k
FGLFounder Group Limited	US$ 2.945 (-27.82%)	9.79M
SMXSMX Security Matters Public Company	US$ 0.5322 (173.20%)	486.42M
SVMHSRIVARU Holding Ltd	US$ 0.02715 (23.41%)	437.75M
HTOOFusion Fuel Green PLC	US$ 0.535 (68.24%)	268.78M
CNEYCN Energy Group Inc	US$ 0.5802 (83.84%)	149.36M
SRMSRM Entertainment Inc	US$ 1.1301 (79.35%)	132.23M